tris(2,3-dibromopropyl)phosphate has been researched along with Neuroblastoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mańdziuk, M; Skóra, B; Szychowski, KA | 1 |
1 other study(ies) available for tris(2,3-dibromopropyl)phosphate and Neuroblastoma
| Article | Year |
|---|---|
Tris (2,3-Dibromopropyl) Isocyanurate (TDBP-TAZTO or TBC) Shows Different Toxicity Depending on the Degree of Differentiation of the Human Neuroblastoma (SH-SY5Y) Cell Line.
Topics: Basic Helix-Loop-Helix Transcription Factors; Cell Differentiation; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Flame Retardants; Humans; Neuroblastoma; Organophosphates; Reactive Oxygen Species; Receptors, Aryl Hydrocarbon | 2021 |